indomethacin has been researched along with Erosive Duodenitis in 5 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
" This study was designed to investigate the effects of a recently developed biotechnological product, a nano-formulation of olmesartan medoxomil (OM) - olmesartan medoxomil zeinmersomes (OMZ) - for the treatment of indomethacin-induced duodenitis in rats." | 8.31 | A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats. ( Alqurashi, TM; Murad, HA, 2023) |
"The effect of ketoprofen, a nonsteroidal anti-inflammatory drug, was tested on the upper gastrointestinal tract (UGIT) in patients with osteoarthritis." | 5.06 | A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis. ( Collins, AJ; Davies, J; Dixon, AS, 1988) |
" This study was designed to investigate the effects of a recently developed biotechnological product, a nano-formulation of olmesartan medoxomil (OM) - olmesartan medoxomil zeinmersomes (OMZ) - for the treatment of indomethacin-induced duodenitis in rats." | 4.31 | A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats. ( Alqurashi, TM; Murad, HA, 2023) |
" The bioavailability of indomethacin in the three groups does not differ significantly." | 2.66 | Protective effect of rioprostil on indomethacin-induced lesions of gastric and duodenal mucosa in healthy volunteers. ( Gerova, Z; Kirkov, V; Popov, P; Vlahov, V, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Murad, HA | 1 |
Alqurashi, TM | 1 |
Ivey, KJ | 1 |
Swift, GL | 1 |
Arnold, J | 1 |
Williams, GT | 1 |
Williams, BD | 1 |
Rhodes, J | 1 |
Khan, F | 1 |
Vlahov, V | 1 |
Kirkov, V | 1 |
Popov, P | 1 |
Gerova, Z | 1 |
Collins, AJ | 1 |
Davies, J | 1 |
Dixon, AS | 1 |
3 trials available for indomethacin and Erosive Duodenitis
Article | Year |
---|---|
A comparison of upper gastrointestinal mucosal damage by standard and delayed-release indomethacin.
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Double-Blind Method; Duodenal Ulcer; Du | 1992 |
Protective effect of rioprostil on indomethacin-induced lesions of gastric and duodenal mucosa in healthy volunteers.
Topics: Adult; Anti-Ulcer Agents; Double-Blind Method; Duodenitis; Gastritis; Humans; Indomethacin; Male; Pr | 1989 |
A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis.
Topics: Administration, Oral; Delayed-Action Preparations; Double-Blind Method; Duodenitis; Endoscopy; Esoph | 1988 |
2 other studies available for indomethacin and Erosive Duodenitis
Article | Year |
---|---|
A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats.
Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Caspase 3; Duodenitis; Indomethacin; | 2023 |
Drugs, gastritis, and peptic ulcer.
Topics: Acetaminophen; Animals; Aspirin; Bicarbonates; Cimetidine; Duodenitis; Gastric Acid; Gastric Mucosa; | 1981 |